posteditor

posteditor

Houston Clinic Reveals Safe, Legal Path Through FDA Peptide Crackdown

Houston Regenerative Medicine offers medically supervised peptide protocols sourced from licensed compounding pharmacies as federal regulators tighten restrictions on unvetted research chemicals. Houston, Texas – April 29, 2026 – Houston Regenerative Medicine, a physician-founded regenerative practice serving patients across the Greater…

Phase III Trial Enrollment Reached (75%) for Promising Anti-Inflammatory and Anti-Fibrotic Cardiac Therapies by Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

$CRDL Target Recruitment Anticipated by End of Q2 2026, with Potential to Extend into Q3 to Accommodate Enrollment from Additional Clinical Sites Late-Stage Life Sciences Company Focused on Advancing Development of Anti-Inflammatory and Anti-Fibrotic Therapies for Heart Disease. CardiolRx™, Modulates…